- Home
- TRN vs CPRX Comparison
TRN vs CPRX Comparison
Compare TRN & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRN
- CPRX
- Stock Information
- Founded
- TRN 1933
- CPRX 2002
- Country
- TRN United States
- CPRX United States
- Employees
- TRN N/A
- CPRX N/A
- Industry
- TRN Railroads
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- TRN Industrials
- CPRX Health Care
- Exchange
- TRN Nasdaq
- CPRX Nasdaq
- Market Cap
- TRN 2.2B
- CPRX 2.6B
- IPO Year
- TRN N/A
- CPRX 2006
- Fundamental
- Price
- TRN $27.96
- CPRX $21.06
- Analyst Decision
- TRN Hold
- CPRX Strong Buy
- Analyst Count
- TRN 1
- CPRX 5
- Target Price
- TRN $24.00
- CPRX $33.20
- AVG Volume (30 Days)
- TRN 490.5K
- CPRX 1.6M
- Earning Date
- TRN 10-30-2025
- CPRX 11-05-2025
- Dividend Yield
- TRN 4.29%
- CPRX N/A
- EPS Growth
- TRN N/A
- CPRX 183.96
- EPS
- TRN 1.14
- CPRX 1.65
- Revenue
- TRN $2,519,800,000.00
- CPRX $558,499,000.00
- Revenue This Year
- TRN N/A
- CPRX $16.51
- Revenue Next Year
- TRN $7.24
- CPRX $9.58
- P/E Ratio
- TRN $24.53
- CPRX $12.38
- Revenue Growth
- TRN N/A
- CPRX 28.55
- 52 Week Low
- TRN $22.38
- CPRX $19.05
- 52 Week High
- TRN $39.83
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- TRN 48.88
- CPRX 58.36
- Support Level
- TRN $27.44
- CPRX $20.34
- Resistance Level
- TRN $28.40
- CPRX $21.22
- Average True Range (ATR)
- TRN 0.52
- CPRX 0.62
- MACD
- TRN -0.04
- CPRX 0.13
- Stochastic Oscillator
- TRN 31.11
- CPRX 65.66
About TRN Trinity Industries Inc.
Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).